Dennis Haas, Ph.D., J.D.
Dennis has broad experience in the Life Sciences industry. Before joining Riverside Law, Dennis worked as an associate in a large Philadelphia-based law firm and as patent counsel in the biopharmaceuticals group of a large multinational pharmaceutical company.
Prior to earning his law degree from the University of Pennsylvania Law School in 2007, Dennis completed doctoral studies in molecular microbiology and immunology at the University of Southern California in 2003. His doctoral research was focused on the genetic modification of hematopoietic progenitor cells and the expression of transgenes during hematopoiesis. He is well versed in life sciences patent law, including biopharmaceuticals, pharmaceuticals, biotechnology, genomics, and medical devices. He is experienced in patent preparation and prosecution, post-grant procedure, due diligence, preparing infringement, non-infringement and invalidity opinions, as well as strategic counseling and patent portfolio management. He is admitted to practice in Pennsylvania and is registered to practice before the U.S. Patent and Trademark Office.
Quang D. Nguyen, Ph.D., J.D.
Quang began practicing patent law in 2003 as a patent agent, focusing mainly on the Life Sciences. Quang received his bachelor’s degree in biology from West Chester University in 1997 and his Ph.D. in molecular biology and genetics from Temple University School of Medicine in 2003. While at Temple, Quang investigated the role of cellular signaling during embryonic stem cell differentiation and the role of JNK scaffolding proteins in tethering signal transduction proteins to cytoskeletal proteins and transcription factors in the laboratory of Dr. Premkumar Reddy. Quang’s industry experience includes several years as a molecular biologist at DuPont where he generated bacterial and yeast knockout strains, and as a research assistant at a biotech company where he developed hybridoma cell lines.
Quang has many years of experience as a patent agent and focuses on the procurement of patents for a wide variety of clients. Quang also has particular experience in inventorship/ownership disputes having assisted in a major stem cell litigation for many years. Quang completed law school at the Temple University Beasley School of Law in 2011. He is admitted to practice in Pennsylvania and New Jersey and is registered to practice before the U.S. Patent and Trademark Office
Pallab Singh, Ph.D., J.D.
Pallab has over ten years of experience working on the commercialization and patent protection of technologies in the fields of biologics, biotechnology, bioengineering and medical devices.
Pallab received his bachelor’s degree in biomedical engineering with a minor in biology from the University of Rochester in 2004. He earned a Ph.D. in bioengineering from the University of Pennsylvania in 2011, where he investigated the neuronal response to traumatic brain injury. During his graduate work, Pallab worked at the Center for Technology Transfer at the University of Pennsylvania where he performed technology assessments and conducted patentability evaluations of university technologies. During his time at Riverside Law, Pallab has gained extensive experience working with a wide variety of clients in patent preparation and prosecution, patent strategy, portfolio management and due diligence.
Pallab earned his law degree (summa cum laude) from Temple University Beasley School of Law in 2019. During his legal studies, Pallab received the Albert L. Bricklin Memorial Award for achieving the highest cumulative grade point average in the Evening Division and the Robert C. Podwil Memorial Prize for excellence in academic performance in intellectual property.
Alison Slaughter, Ph.D.
Alison is a patent agent with more than six years of industrial and academic research experience in biology and chemistry. She received her bachelor's degree in chemistry from the University of Cincinnati in 2009 and her Ph.D. in pharmaceutics and pharmaceutical chemistry in 2015. Alison’s doctoral research focused on the mechanism of action of preclinical HIV-1 inhibitors and the rational design of second-generation inhibitors.
Natalie Fonville, Ph.D.
Natalie is a patent agent with expertise in biological sciences and bioinformatics. Natalie received her Ph.D. in cell and molecular biology from Baylor College of Medicine in 2010. She then conducted post-doctoral research at MD Anderson in the area of human genetics and at Virginia Bioinformatics Institute on human and cancer genomics. Her thesis was titled “SOS and RecQ pathways in thymineless death and genomic stability in E. coli,” and her most recent focus has been on the identification of novel biomarkers as risk-indicators of breast and ovarian cancer predisposition.
Ming Chen, B. Eng., J.D.
Ming received a bachelor’s degree in biomedical engineering from Drexel University, where he concentrated in areas including biomaterials and tissue engineering, particularly as they apply to medical devices and implants. Ming has also worked on projects with Johnson & Johnson and Merck, where he developed immunoassays and took part in siRNA animal studies.
After graduating from the University of Michigan Law School, Ming handled patent and marketing due diligence matters for university inventions in Drexel’s Office of Technology Commercialization. He is admitted to practice in New Jersey, and is registered to practice before the U.S. Patent and Trademark Office.
Sogol Baharlou, Ph.D.
Sogol is a scientific advisor with research experience in the fields of tissue engineering, regenerative medicine and drug delivery.
Sogol earned her Ph.D. in bioengineering from Temple University in 2017, where she investigated soy protein based scaffolds for skin tissue engineering and wound healing.
During her graduate work, Sogol worked at the Office of Technology Commercialization and Business Development at Temple University where she performed technology assessments, conducted patentability evaluations, and performed preliminary market and industry analysis for a wide variety of inventions in the life sciences and medical device fields.